Edition:
India

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

70.18EUR
19 Mar 2019
Change (% chg)

€0.82 (+1.18%)
Prev Close
€69.36
Open
€69.32
Day's High
€70.22
Day's Low
€69.00
Volume
628,694
Avg. Vol
1,020,908
52-wk High
€91.74
52-wk Low
€55.44

Chart for

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)

Overall

Beta: 0.37
Market Cap(Mil.): €25,665.52
Shares Outstanding(Mil.): 307.96
Dividend: 0.96
Yield (%): 1.15

Financials

FMC wraps up $2 bln acquisition of NxStage

BERLIN, Feb 22 Germany's Fresenius Medical Care (FMC) wrapped up its $2 billion acquisition of U.S. home dialysis maker NxStage Medical on Friday, according to a U.S. Securities and Exchange Commission filing.

22 Feb 2019

FMC expects NxStage deal to close in next couple of days

BERLIN Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

20 Feb 2019

UPDATE 2-Fresenius flags faster earnings growth from 2020 after investment

* Announces 1 bln euros share buyback at Fresenius Medical Care

20 Feb 2019

FMC expects NxStage deal to close in next couple of days

BERLIN, Feb 20 Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

20 Feb 2019

RPT-Fresenius Medical Care plans 1 bln eur share buyback

BERLIN, Feb 20 Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

20 Feb 2019

Fresenius Medical Care plans 1 bln eur share buyback

BERLIN, Feb 20 Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

20 Feb 2019

Fresenius expects earnings to stagnate in 2019 as investments weigh

BERLIN, Feb 20 German healthcare group Fresenius said sales growth would slow and profit stagnate this year as investments to fix the performance at its German hospitals business and build up home dialysis take a toll.

20 Feb 2019

U.S. approves Fresenius purchase of NxStage

WASHINGTON The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

20 Feb 2019

U.S. approves Fresenius purchase of NxStage

WASHINGTON The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

20 Feb 2019

UPDATE 2-U.S. approves Fresenius purchase of NxStage

WASHINGTON, Feb 19 The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

20 Feb 2019

Earnings vs. Estimates